Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#141 / 200 Total
AP - Ampco-Pittsburgh Corp - Stock Price Chart
TickerAP [NYSE]
CompanyAmpco-Pittsburgh Corp
CountryUSA
IndustryMetal Fabrication
Market Cap68.13MEPS (ttm)0.21
P/E15.77EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.17EPS next 5Y-
P/B1.05EPS Q/Q141.10%
Dividend-Sales Q/Q-5.40%
Insider Own28.06%Inst Own47.38%
Insider Trans0.07%Inst Trans0.13%
Short Float2.87%EarningsMay 13/b
Analyst Recom3.00Target Price5.00
Avg Volume67.74K52W Range1.26 - 3.99
Ampco-Pittsburgh Corp. is engaged in the manufacture and sale of custom designed engineering products. It operates through the Forged and Cast Engineered Products, and Air and Liquid Processing segments. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls and open-die forged products. Forged hardened steel rolls are used primarily in cold rolling mills by producers of steel, aluminum and other metals. The Air and Liquid Processing segment includes the Aerofin, Buffalo Air Handling, and Buffalo Pumps divisions. The company was founded in 1929 and is headquartered in Carnegie, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fessenden Elizabeth AnneDirectorMar 24 '25Buy2.232,4005,363105,222Mar 26 10:20 AM
Fessenden Elizabeth AnneDirectorMar 25 '25Buy2.161,3802,981106,602Mar 26 10:20 AM
SMSI - Smith Micro Software, Inc - Stock Price Chart
TickerSMSI [NASD]
CompanySmith Micro Software, Inc
CountryUSA
IndustrySoftware - Application
Market Cap21.94MEPS (ttm)-1.73
P/E-EPS this Y78.43%
Forward P/E-EPS next Y68.24%
PEG-EPS past 5Y-
P/S1.13EPS next 5Y-
P/B0.60EPS Q/Q91.32%
Dividend-Sales Q/Q-20.30%
Insider Own24.66%Inst Own6.62%
Insider Trans-0.21%Inst Trans8.67%
Short Float0.87%EarningsMay 07/a
Analyst Recom1.00Target Price4.00
Avg Volume158.05K52W Range0.52 - 2.57
Smith Micro Software, Inc. engages in the provision of software solutions. It offers wireless internet solutions which enable access to information and entertainment. Its products include SafePath Family, SafePath IoT, SafePath Home, CommSuite VVM, CommSuite VTT, and ViewSpot. The company was founded by William W. Smith Jr. on November 30, 1982 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CAMPBELL THOMAS GDirectorMar 14 '25Sale0.7110,0007,10029,213Mar 17 04:33 PM
Thomas G. CampbellDirectorMar 14 '25Proposed Sale0.7110,0007,100Mar 14 04:28 PM
Kempton James MVP, CFO and TreasurerDec 16 '24Sale0.7943734570,329Dec 18 06:11 PM
Kempton James MOfficerDec 16 '24Proposed Sale0.79437345Dec 16 02:36 PM
SMITH WILLIAM W JRPresident & CEODec 03 '24Sale0.787,0665,5123,194,533Dec 04 08:48 PM
HIMS - Hims & Hers Health Inc - Stock Price Chart
TickerHIMS [NYSE, RUT]
CompanyHims & Hers Health Inc
CountryUSA
IndustryHousehold & Personal Products
Market Cap11.65BEPS (ttm)0.69
P/E75.74EPS this Y27.49%
Forward P/E53.69EPS next Y43.43%
PEG2.19EPS past 5Y17.22%
P/S6.53EPS next 5Y34.58%
P/B21.18EPS Q/Q313.81%
Dividend-Sales Q/Q110.67%
Insider Own14.80%Inst Own70.41%
Insider Trans-5.50%Inst Trans-4.09%
Short Float35.84%EarningsMay 05/a
Analyst Recom2.73Target Price46.73
Avg Volume46.14M52W Range13.47 - 72.98
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boughton SoleilOfficerJul 14 '25Proposed Sale47.822,572122,993Jul 14 12:25 PM
Melissa BairdOfficerJul 08 '25Proposed Sale48.9633,3331,631,984Jul 08 04:48 PM
Okupe OluyemiChief Financial OfficerJul 07 '25Option Exercise5.016,43732,24969,659Jul 08 04:40 PM
Okupe OluyemiChief Financial OfficerJul 07 '25Sale46.6711,581540,49858,078Jul 08 04:40 PM
Boughton SoleilChief Legal OfficerJun 30 '25Sale50.502,572129,886160,737Jul 01 04:45 PM
ALMU - Aeluma Inc - Stock Price Chart
TickerALMU [NASD, RUT]
CompanyAeluma Inc
CountryUSA
IndustrySemiconductors
Market Cap268.05MEPS (ttm)-0.27
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S73.84EPS next 5Y-
P/B14.89EPS Q/Q239.82%
Dividend-Sales Q/Q264.93%
Insider Own48.81%Inst Own5.62%
Insider Trans0.00%Inst Trans-2.06%
Short Float8.53%Earnings-
Analyst Recom-Target Price-
Avg Volume327.44K52W Range2.50 - 19.50
TodayInitiated Craig Hallum Buy $26
Aeluma, Inc. engages in the business of developing novel optoelectronic devices for sensing and communications applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.
CREV - Carbon Revolution Public Ltd. Co - Stock Price Chart
TickerCREV [NASD]
CompanyCarbon Revolution Public Ltd. Co
CountryIreland
IndustryAuto Parts
Market Cap10.03MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-80.46%
Dividend-Sales Q/Q-
Insider Own7.11%Inst Own1.34%
Insider Trans0.00%Inst Trans-
Short Float8.64%Earnings-
Analyst Recom1.00Target Price39.00
Avg Volume377.66K52W Range2.00 - 14.19
Carbon Revolution Plc engages in the manufacturing of advanced carbon fiber wheels. The firm is currently supplying wheels to the automotive market for vehicles and SUVs and is developing wheels for EVs under contract for its OEM customers. The company is headquartered in Dublin, Ireland.
ILPT - Industrial Logistics Properties Trust - Stock Price Chart
TickerILPT [NASD, RUT]
CompanyIndustrial Logistics Properties Trust
CountryUSA
IndustryREIT - Industrial
Market Cap396.19MEPS (ttm)-1.43
P/E-EPS this Y38.36%
Forward P/E-EPS next Y30.56%
PEG-EPS past 5Y-
P/S0.90EPS next 5Y57.76%
P/B0.73EPS Q/Q8.38%
Dividend1.84%Sales Q/Q-0.29%
Insider Own21.16%Inst Own47.05%
Insider Trans0.14%Inst Trans-3.98%
Short Float2.05%EarningsJul 29/a
Analyst Recom2.00Target Price5.95
Avg Volume445.71K52W Range2.45 - 5.57
Industrial Logistics Properties Trust is a real estate investment trust, which owns and leases industrial and logistics properties. The company was founded on September 15, 2017, and is headquartered in Newton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morea JosephDirectorMay 30 '25Buy3.3120,00066,228112,191Jun 02 04:24 PM
PHELAN KEVIN CDirectorAug 02 '24Buy4.752,0009,49910,500Aug 20 05:56 PM
SGHT - Sight Sciences Inc - Stock Price Chart
TickerSGHT [NASD, RUT]
CompanySight Sciences Inc
CountryUSA
IndustryMedical Devices
Market Cap191.29MEPS (ttm)-0.98
P/E-EPS this Y-3.28%
Forward P/E-EPS next Y15.35%
PEG-EPS past 5Y-13.18%
P/S2.45EPS next 5Y11.93%
P/B2.45EPS Q/Q16.03%
Dividend-Sales Q/Q-9.12%
Insider Own47.67%Inst Own30.92%
Insider Trans0.66%Inst Trans-10.29%
Short Float4.54%EarningsMay 08/a
Analyst Recom2.43Target Price3.77
Avg Volume172.83K52W Range2.03 - 8.45
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HAYDEN JEREMY B.Chief Legal OfficerJul 03 '25Sale4.179,16038,234266,321Jul 07 09:32 PM
Bauerlein AlisonChief Financial OfficerJul 02 '25Sale4.1019,26078,927617,468Jul 07 09:27 PM
Badawi PaulPresident and CEOJul 01 '25Sale4.1523,63798,1415,986,943Jul 07 09:27 PM
Badawi DavidChief Technology OfficerJul 03 '25Sale4.175,67923,7041,831,025Jul 07 09:25 PM
Link MatthewChief Commercial OfficerJul 02 '25Sale4.104,88920,035832,293Jul 07 09:24 PM
LTRN - Lantern Pharma Inc - Stock Price Chart
TickerLTRN [NASD]
CompanyLantern Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap43.03MEPS (ttm)-1.84
P/E-EPS this Y4.66%
Forward P/E-EPS next Y-6.52%
PEG-EPS past 5Y-37.87%
P/S-EPS next 5Y-2.53%
P/B2.56EPS Q/Q16.94%
Dividend-Sales Q/Q-
Insider Own24.31%Inst Own11.37%
Insider Trans-10.75%Inst Trans-15.29%
Short Float3.21%EarningsMay 15/b
Analyst Recom1.00Target Price25.00
Avg Volume127.65K52W Range2.55 - 6.12
Jun-16-25 08:30AM Lung Cancer Patient in Lantern Pharma's Harmonic Trial Shows Durable Complete Response in Target Cancer Lesions with Survival Continuing for Nearly Two Years (Business Wire)
May-29-25 11:21PM Lantern Pharma Inc. (LTRN)'s LP-184 Shows 345% Survival Gain in Rare Pediatric Brain Tumor Models (Insider Monkey) +9.06%
08:30AM Lantern Pharma's LP-184 Shows Promising In Vivo Activity in Atypical Teratoid Rhabdoid Tumors (ATRT) at SNO Pediatric Conference, Further Validating Rare Pediatric Disease Designation and Pathway to Clinical Trials (Business Wire)
May-15-25 08:45AM Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates (Business Wire)
May-12-25 09:00AM Lantern Pharma Secures FDA Clearance for Planned Phase 1b/2 Trial of LP-184 in Biomarker-Defined, Treatment-Resistant NSCLC Patients with High Unmet Clinical Need (Business Wire)
08:31AM EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients (Benzinga)
May-08-25 08:30AM Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET (Business Wire) -11.06%
May-05-25 08:55AM Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC) (Business Wire)
08:31AM EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial (Benzinga)
Apr-01-25 09:01PM Lantern Pharma Inc (LTRN) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com) -6.50%
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fletcher Aaron G.L.10% OwnerJun 13 '25Sale3.0940,000123,60049,957Jun 13 07:57 PM
Kreis Leslie W.10% OwnerJun 13 '25Sale3.0940,000123,60049,957Jun 13 07:50 PM
Fletcher Aaron G.L.10% OwnerJun 12 '25Sale3.3860,647204,98751,860Jun 13 06:06 AM
Fletcher Aaron G.L.10% OwnerJun 11 '25Sale3.409503,23054,746Jun 13 06:06 AM
Fletcher Aaron G.L.10% OwnerJun 10 '25Sale3.40165454,791Jun 13 06:06 AM
FORD - Forward Industries, Inc - Stock Price Chart
TickerFORD [NASD]
CompanyForward Industries, Inc
CountryUSA
IndustryFootwear & Accessories
Market Cap9.87MEPS (ttm)-2.91
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y14.07%
P/S0.40EPS next 5Y-
P/B-EPS Q/Q-139.80%
Dividend-Sales Q/Q-60.12%
Insider Own18.08%Inst Own8.26%
Insider Trans0.00%Inst Trans-12.05%
Short Float3.39%Earnings-
Analyst Recom-Target Price-
Avg Volume23.83K52W Range3.10 - 8.99
Forward Industries, Inc. engages in the provision of integrated design, development, and manufacturing solutions for top tier medical and technology customers worldwide. It operates through the following segments: OEM Distribution, Retail Distribution, and Design. The OEM Distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices. The Retail Distribution segment sells smart-enabled furniture and a variety of other products through agreements with various retailers, both in stores and through online retailer websites. The Design segment provides hardware and software product design and engineering services. The company was founded in 1961 and is headquartered in Hauppauge, NY.
HOWL - Werewolf Therapeutics Inc - Stock Price Chart
TickerHOWL [NASD]
CompanyWerewolf Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap57.89MEPS (ttm)-1.64
P/E-EPS this Y-6.99%
Forward P/E-EPS next Y1.61%
PEG-EPS past 5Y-20.76%
P/S50.78EPS next 5Y-3.68%
P/B1.01EPS Q/Q-3.67%
Dividend-Sales Q/Q-100.00%
Insider Own26.20%Inst Own47.56%
Insider Trans4.70%Inst Trans-3.56%
Short Float4.00%EarningsMay 08/b
Analyst Recom1.00Target Price8.40
Avg Volume520.81K52W Range0.60 - 4.18
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RA CAPITAL MANAGEMENT, L.P.DirectorMay 12 '25Buy0.86320,913275,9856,021,969May 14 06:08 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMay 14 '25Buy0.98162,539159,2886,237,482May 14 06:08 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMay 13 '25Buy0.9852,97451,9156,074,943May 14 06:08 PM
MPM BioVentures 2014, L.P.10% OwnerMar 27 '25Sale1.051,9632,0613,208,793Apr 30 04:17 PM
EVNIN LUKEDirectorMar 27 '25Sale1.052,4252,5464,309,860Apr 30 04:09 PM
11011121314151617181920